Stephen Luen is a Medical Oncologist and translational researcher at the Peter MacCallum Cancer Centre with specialist interests in breast cancer, sarcoma, and phase 1 trials. He completed his PhD under the primary supervision of Professor Sherene Loi in 2021 investigating genomic landscapes and drivers in hormone receptor-positive, HER2-negative early breast cancers, and continues to work closely with the lab as a postdoctoral scientist.

His current research interests include the study of genomic and immune biomarkers in breast cancer, with a particular focus on investigating biological characteristics and developing clinical trials for high-risk subgroups of patients. Additionally, he has research interests in Precision Oncology approaches, and the clinical development of novel therapeutic agents through early-phase clinical trials.